20:04 , Apr 25, 2019 |  BC Innovations  |  Finance

The academic founders' conundrum

First-time academic entrepreneurs face a circular problem: while they’re continually sought after by VCs and pharmas seeking the next “big thing”, they also face an arduous path to establish their bona fides - not for...
19:37 , Apr 20, 2018 |  Completed Offerings  |  Completed Offerings

Tmunity adds $35M to series A round

T cell immunotherapy company Tmunity Therapeutics Inc. (Philadelphia, Pa.) raised an additional $35 million for its series A round from Kleiner Perkins and affiliates, bringing the round's total to $135 million. In January, the company...
11:08 , Apr 19, 2018 |  BC Extra  |  Financial News

Tmunity tops off series A round

T cell immunotherapy company Tmunity Therapeutics Inc. (Philadelphia, Pa.) raised an additional $35 million for its series A round from Kleiner Perkins and affiliates, bringing the round's total to $135 million. In January, the company...
13:43 , Apr 13, 2018 |  BC Week In Review  |  Financial News

Magenta Therapeutics raises $52M series C

Stem cell therapy company Magenta Therapeutics Inc. (Cambridge, Mass.) raised $52 million on April 9 in an untranched, oversubscribed series C round led by Casdin Capital. New investors EcoR1 Capital, Eventide and Watermill were joined...
23:20 , Apr 9, 2018 |  BC Extra  |  Financial News

Magenta Therapeutics raises $52M series C

Magenta Therapeutics Inc. (Cambridge, Mass.) raised $52 million in an untranched, oversubscribed series C round led by Casdin Capital. New investors EcoR1 Capital, Eventide and Watermill were joined by existing investors Be the Match BioTherapies...
23:24 , Jan 26, 2018 |  BioCentury  |  Finance

Tmunity’s A team

An all-star team with a proven track record in cell therapy enabled Tmunity Therapeutics Inc. to raise a $100 million series A round that included opportunistic investments from non-profits Be the Match BioTherapies and Parker...
17:09 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Tmunity raises $100M series A

T cell immunotherapy company Tmunity Therapeutics Inc. (Philadelphia, Pa.) raised $100 million in a series A round Tuesday from new investors Ping An Ventures, Parker Institute for Cancer Immunotherapy, Gilead Sciences Inc. (NASDAQ:GILD) and Be...
00:31 , Jan 24, 2018 |  BC Extra  |  Financial News

Tmunity raises $100M series A

T cell immunotherapy company Tmunity Therapeutics Inc. (Philadelphia, Pa.) raised $100 million in a series A round Tuesday from new investors Ping An Ventures, Parker Institute for Cancer Immunotherapy, Gilead Sciences Inc. (NASDAQ:GILD) and Be...
21:52 , May 5, 2017 |  BioCentury  |  Finance

Magenta’s match

Be the Match BioTherapies’ first ever equity investment was motivated by desire to back a company that shared its goal of helping transplant patients achieve better outcomes, rather than by a planned strategic shift toward...
20:00 , May 5, 2017 |  BC Week In Review  |  Company News

National Marrow Donor Program, Magenta in cell therapy platform and service access deal

The Be The Match BioTherapies subsidiary of the National Marrow Donor Program (Minneapolis, Minn.) granted Magenta Therapeutics Inc. (Cambridge, Mass.) non-exclusive access to its cell therapy delivery platform, industry relationships and clinical trial design and...